
Fulltext:
88766.pdf
Embargo:
until further notice
Size:
74.18Kb
Format:
PDF
Description:
publisher's version
Publication year
2010Source
Proteomics Clinical Applications, 4, 12, (2010), pp. 922-925ISSN
Annotation
1 december 2010
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Pathology
Journal title
Proteomics Clinical Applications
Volume
vol. 4
Issue
iss. 12
Page start
p. 922
Page end
p. 925
Subject
ONCOL 3: Translational researchAbstract
The introduction in pathology practice of a new biomarker that is contributing to define a disease requires a series of investigations. Now that new biomarkers are being discovered continuously it is important to learn from successful examples of markers that are presently widely used. In this historical account the steps are described that have led to the use of immunohistochemical staining of tissue samples with an antibody against cyclinD1 to diagnose mantle cell lymphoma. Furthermore, a short outlook is given on the introduction of proteomics as a tool in the diagnosis of lymphoma and the potential route to be taken for introducing this technology into clinical practice.
This item appears in the following Collection(s)
- Academic publications [202863]
- Electronic publications [101087]
- Faculty of Medical Sciences [80039]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.